Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Thorne

Showing results (331-340 of 405) with videos related to

Pageof 41
Sort By:
Ophthalmology|November 29, 2024
Macular Edema Ranibizumab versus Intravitreal Anti-inflammatory Therapy Trial: 24-Week Outcomes of Uveitic Macular Edema Re-treatment, John Gonzales, Nisha R Acharya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 9, 2024
The Association of Anemia With Survival Among People With HIV Following Antiretroviral Initiation in the NA-ACCORD 2007-2016Raynell Lang, Sally B Coburn, M John Gill, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2016
Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV TreatmentJohn R Koethe, Cathy A Jenkins, Bryan Lau, et al.
The British Journal of Ophthalmology|June 27, 2020
Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemicRupesh Agrawal, Ilaria Testi, Cecilia S Lee, et al.
Ophthalmology|April 24, 2017
Risk of Ocular Hypertension in Adults with Noninfectious UveitisEbenezer Daniel, Maxwell Pistilli, Srishti Kothari, et al.
American Journal of Ophthalmology|April 6, 2019
Remission of Non-Infectious Anterior Scleritis: Incidence and Predictive FactorsJohn H Kempen, Maxwell Pistilli, Hosne Begum, et al.
Ophthalmology. Retina|May 12, 2026
Evidence and Consensus Based Imaging Guidelines in Cytomegalovirus retinitis. Multimodal imaging in Uveitis (MUV) Taskforce Report 15Inês Leal, Aniruddha Agarwal, Meghan Berkenstock, et al.
American Journal of Ophthalmology|January 17, 2016
Remission of Intermediate Uveitis: Incidence and Predictive FactorsJohn H Kempen, Dina Y Gewaily, Craig W Newcomb, et al.
Ocular Immunology and Inflammation|March 23, 2016
Adalimumab for Ocular InflammationKhayyam Durrani, John H Kempen, Gui-Shuang Ying, et al.
The New England Journal of Medicine|September 8, 2016
Adalimumab in Patients with Active Noninfectious UveitisGlenn J Jaffe, Andrew D Dick, Antoine P Brézin, et al.
Pageof 41

Showing results (331-340 of 405) with videos related to

Sort By:
Pageof 41
Ophthalmology|November 29, 2024
Macular Edema Ranibizumab versus Intravitreal Anti-inflammatory Therapy Trial: 24-Week Outcomes of Uveitic Macular Edema Re-treatment, John Gonzales, Nisha R Acharya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 9, 2024
The Association of Anemia With Survival Among People With HIV Following Antiretroviral Initiation in the NA-ACCORD 2007-2016Raynell Lang, Sally B Coburn, M John Gill, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2016
Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV TreatmentJohn R Koethe, Cathy A Jenkins, Bryan Lau, et al.
The British Journal of Ophthalmology|June 27, 2020
Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemicRupesh Agrawal, Ilaria Testi, Cecilia S Lee, et al.
Ophthalmology|April 24, 2017
Risk of Ocular Hypertension in Adults with Noninfectious UveitisEbenezer Daniel, Maxwell Pistilli, Srishti Kothari, et al.
American Journal of Ophthalmology|April 6, 2019
Remission of Non-Infectious Anterior Scleritis: Incidence and Predictive FactorsJohn H Kempen, Maxwell Pistilli, Hosne Begum, et al.
Ophthalmology. Retina|May 12, 2026
Evidence and Consensus Based Imaging Guidelines in Cytomegalovirus retinitis. Multimodal imaging in Uveitis (MUV) Taskforce Report 15Inês Leal, Aniruddha Agarwal, Meghan Berkenstock, et al.
American Journal of Ophthalmology|January 17, 2016
Remission of Intermediate Uveitis: Incidence and Predictive FactorsJohn H Kempen, Dina Y Gewaily, Craig W Newcomb, et al.
Ocular Immunology and Inflammation|March 23, 2016
Adalimumab for Ocular InflammationKhayyam Durrani, John H Kempen, Gui-Shuang Ying, et al.
The New England Journal of Medicine|September 8, 2016
Adalimumab in Patients with Active Noninfectious UveitisGlenn J Jaffe, Andrew D Dick, Antoine P Brézin, et al.
Pageof 41